AARDVARK THERAPEUTICS INC (AARD) Stock Overview
USA - NASDAQ:AARD - US0029421007 - Common Stock
AARD Key Statistics, Chart & Performance
The current stock price of AARD is 10.89 USD. In the past month the price increased by 11.92%.
AARD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 46.56 | 711.73B | ||
| JNJ | JOHNSON & JOHNSON | 17.62 | 424.33B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 15.62 | 272.83B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.89 | 237.97B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 17.18 | 236.50B | ||
| MRK | MERCK & CO. INC. | 10.59 | 203.59B | ||
| PFE | PFIZER INC | 7.09 | 136.62B | ||
| SNY | SANOFI-ADR | 10.71 | 116.19B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.69 | 91.64B | ||
| GSK | GSK PLC-SPON ADR | 9 | 81.93B | ||
| ZTS | ZOETIS INC | 23.45 | 64.65B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 51.93 | 47.56B |
Related stock screener links
About AARD
Company Profile
Aardvark Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in San Diego, California and currently employs 31 full-time employees. The company went IPO on 2025-02-13. The firm targets biological pathways associated with alleviating hunger that has the potential to deliver transformative outcomes for patients. The company is focused on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its initial compounds target TAS2Rs expressed in the gut lumen, which normally respond to the nutrients in food and participate in the gut-brain axis. Its wholly owned lead product candidate, ARD-101 (denatonium acetate monohydrate), is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which it has initiated a Phase III clinical trial for hyperphagia associated with Prader-Willi Syndrome (PWS).
Company Info
AARDVARK THERAPEUTICS INC
4370 La Jolla Village Drive, Suite 1050
San Diego CALIFORNIA US
Employees: 31
Phone: 18582257696
AARDVARK THERAPEUTICS INC / AARD FAQ
What is the stock price of AARDVARK THERAPEUTICS INC today?
The current stock price of AARD is 10.89 USD. The price decreased by -3.54% in the last trading session.
What is the ticker symbol for AARDVARK THERAPEUTICS INC stock?
The exchange symbol of AARDVARK THERAPEUTICS INC is AARD and it is listed on the Nasdaq exchange.
On which exchange is AARD stock listed?
AARD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AARDVARK THERAPEUTICS INC stock?
11 analysts have analysed AARD and the average price target is 33.25 USD. This implies a price increase of 205.34% is expected in the next year compared to the current price of 10.89. Check the AARDVARK THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AARDVARK THERAPEUTICS INC worth?
AARDVARK THERAPEUTICS INC (AARD) has a market capitalization of 236.31M USD. This makes AARD a Micro Cap stock.
How many employees does AARDVARK THERAPEUTICS INC have?
AARDVARK THERAPEUTICS INC (AARD) currently has 31 employees.
What are the support and resistance levels for AARDVARK THERAPEUTICS INC (AARD) stock?
AARDVARK THERAPEUTICS INC (AARD) has a support level at 10.88 and a resistance level at 11.3. Check the full technical report for a detailed analysis of AARD support and resistance levels.
Should I buy AARDVARK THERAPEUTICS INC (AARD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AARD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AARD, evaluating the profitability, health, valuation and growth aspects
- AARDVARK THERAPEUTICS INC (AARD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AARDVARK THERAPEUTICS INC (AARD) Sales and EPS estimates to see what analysts future expectations are.
- AARDVARK THERAPEUTICS INC (AARD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AARDVARK THERAPEUTICS INC (AARD) Insider and Institutional Ownership to learn about the owners and their transactions.
- AARDVARK THERAPEUTICS INC (AARD) Stock Chart to make your own analysis
- AARDVARK THERAPEUTICS INC (AARD) Latest news and press-releases to stay up to date.
Does AARDVARK THERAPEUTICS INC (AARD) stock pay dividends?
AARD does not pay a dividend.
What is the Price/Earnings (PE) ratio of AARDVARK THERAPEUTICS INC (AARD)?
AARDVARK THERAPEUTICS INC (AARD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.97).
What is the Short Interest ratio of AARDVARK THERAPEUTICS INC (AARD) stock?
The outstanding short interest for AARDVARK THERAPEUTICS INC (AARD) is 3.59% of its float. Check the ownership tab for more information on the AARD short interest.
AARD Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AARD.
AARD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AARD. AARD has a great financial health rating, but its profitability evaluates not so good.
AARD Financial Highlights
Over the last trailing twelve months AARD reported a non-GAAP Earnings per Share(EPS) of -1.97. The EPS decreased by -185.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -24.84% | ||
| ROE | -26.76% | ||
| Debt/Equity | 0 |
AARD Forecast & Estimates
11 analysts have analysed AARD and the average price target is 33.25 USD. This implies a price increase of 205.34% is expected in the next year compared to the current price of 10.89.